Gland Pharma Ltd board to consider Q3 results on Jan 22, 2021

A meeting of the Board of Directors of the Company is scheduled on 22/01/2021, to consider and approve the Unaudited financial results of the Company for the quarter and nine months ended December 31, 2020.

The trading window will be closed from Friday, 1st January, 2021 and will re-open on Monday, 25th January, 2021.

The Company will hold Investor/analyst calls on Friday, 22nd January, 2021 to discuss the financial results and business outlook.

Shares of Gland Pharma Ltd. was last trading in BSE at Rs. 2382.60 as compared to the previous close of Rs. 2351.30. The total number of shares traded during the day was 11440 at an average price of Rs. 2386.50.

The stock hit an intraday high of Rs. 2404.45 and intraday low of Rs. 2349.65.

Source : Equity Bulls

Keywords